Study of proliferation and apoptosis in neuroblastoma.: Their relation with other prognostic factors

被引:13
|
作者
Mejía, MD [1 ]
Navarro, S
Pellín, A
Ruíz, A
Castel, V
Llombart-Bosch, A
机构
[1] Univ Nacl Autonoma Mexico, Lab LB 302, Dept Neurosci, Inst Fisiol Celular,CU, Mexico City 04510, DF, Mexico
[2] Univ Valencia, Fac Med, Dept Patol, Valencia, Spain
[3] Hosp La Fe, Unidad Oncol Pediat, E-46009 Valencia, Spain
关键词
neuroblastoma; proliferation; apoptosis; prognostic factors;
D O I
10.1016/S0188-4409(02)00384-3
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. Our objective was to study the proliferation and apoptotic process in 111 cases of neuroblastoma (NB) and to seek their relationship with other prognostic factors and survival. Methods. Immunohistochemistry following ABC peroxidase was carried out for PCNA, Ki-67, bcl-2, and p53 proteins. Apoptosis analysis was performed with in situ detection of chromosomal breakdown. Molecular detection of DNA ladders by electrophoresis and amplification of MYCN was studied with PCR and Southern blot. Statistical study was performed with Pearson chi(2) and Kruskal-Wallis tests and Cox regression. Results. Our results indicate that proliferative factors PCNA and Ki-67 were correlated to each other as well as to advanced stage and MYCN amplification. Regarding apoptosis, we found expression of bcl-2 protein in cases of NB without differentiation and advanced stages. p53 protein showed an inverse relation with bcl-2 and cell death measured by assay protein. In situ determination of apoptosis was found mainly in differentiated and stage 4s cases. Multivariate analysis revealed protein as the most independent risk factor of our study. Conclusions. The study of cellular proliferation and apoptosis contributes with information of prognostic value that could be applied to the design of different protocols for treatment of neuroblastoma. (C) 2002 IMSS. Published by Elsevier Science Inc.
引用
收藏
页码:466 / 472
页数:7
相关论文
共 50 条
  • [1] Prognostic significance of cell proliferation in human neuroblastoma:: Comparison with other prognostic factors
    Mejía, C
    Navarro, S
    Pellín, A
    Ruíz, A
    Castel, V
    Llombart-Bosch, A
    ONCOLOGY REPORTS, 2003, 10 (01) : 243 - 247
  • [2] Demographic factors of prognosis in pediatric neuroblastoma.
    Mathews, Maya
    Silberstein, Peter T.
    Swedek, Michelle
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Expression of type I interferon receptor and its relation with other prognostic factors in human neuroblastoma
    Mejía, C
    Navarro, S
    Colamonici, OR
    Pellín, A
    Castel, V
    Llombart-Bosch, A
    ONCOLOGY REPORTS, 1999, 6 (01) : 149 - 153
  • [4] Preclinical study of a PARP inhibitor in neuroblastoma.
    Addioui, Anissa
    Belounis, Assila
    Cournoyer, Sonia
    Nyalendo, Carine
    Brito, Rose-Marie
    Beaunoyer, Mona
    Teira, Pierre
    Sartelet, Herve
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] Phase I study of fenretinide in neuroblastoma.
    Luksch, R
    Pizzitola, MR
    Lo Piccolo, MS
    Formelli, F
    Montaldo, P
    De Bernardi, B
    Bellani, FF
    Garaventa, A
    CLINICAL CANCER RESEARCH, 2000, 6 : 4487S - 4487S
  • [6] Angiogenesis in neuroblastoma:: Relationship to survival and other prognostic factors in a cohort of neuroblastoma patients
    Cañete, A
    Navarro, S
    Bermúdez, J
    Pellín, A
    Castel, V
    Llombart-Bosch, A
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) : 27 - 34
  • [7] A Comprehensive Study on the Diagnosis Methods of Neuroblastoma.
    Hebsiba, F. Li Lly
    Meenal, V.
    Rajalakshmi, V.
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2016, 7 (03): : 825 - 830
  • [8] Principles, history, and relation to other prognostic factors
    Sobin, LH
    CANCER, 2001, 91 (08) : 1589 - 1592
  • [9] Endogenous anti-apoptosis proteins: Contributors to the chemotherapeutic resistance of neuroblastoma.
    Schor, NF
    Nylander, KD
    Cortazzo, MH
    Kassis, ES
    Sproul, KA
    PEDIATRIC RESEARCH, 1996, 39 (04) : 957 - 957
  • [10] Expression of survivin, a novel inhibitor of apoptosis, is associated with unfavorable histology in neuroblastoma.
    Adida, C
    Berrebi, D
    Reyes-Mugica, M
    Altieri, DC
    MODERN PATHOLOGY, 1998, 11 (01) : 166A - 166A